Microorganisms in Recent Drug Discovery

Environmental microbes are a significant source of drug discovery, and several microbial products (anti-tumor products, immunosuppressant, antibiotics and others) are routinely used for human therapy. Most of these products were obtained from cultivable environmental microbes, and this means that the vast majority of microbes were not targeted for drug discovery. With the advent of new and emerging technologies, we are poised to harvest novel drugs from the so-called 'uncultivable' microbes. In this article, we propose how a multidisciplinary approach combining different technologies can expedite and revolutionize drug discovery from uncultivable microbes and examine the current limitations of technologies and strategies to overcome such limitations that might further expand the promise of drugs from environmental microbes.

  • Novel species discovery
  • Novel species discovery
  • Genetically modified organisms

Related Conference of Microorganisms in Recent Drug Discovery

December 04-05, 2023

23rd Global Conference on Gerontology

Venice, Italy
December 15-16, 2023

27th World Congress on Biotechnology

Amsterdam, Netherlands
March 18-19, 2024

53rd World Congress on Microbiology

Zurich, Switzerland
May 09-10, 2024

16th International Virology Summit

Barcelona, Spain

Microorganisms in Recent Drug Discovery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in